A detailed history of Am Squared LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Am Squared LTD holds 200 shares of MRNA stock, worth $7,672. This represents 0.03% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$7,672
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$63.64 - $125.14 $12,728 - $25,028
200 New
200 $13.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Am Squared LTD Portfolio

Follow Am Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Am Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on Am Squared LTD with notifications on news.